Further Evidence of Severe Allergic Contact Dermatitis From Isobornyl Acrylate While Using a Continuous Glucose Monitoring System
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
In the past decade, new diabetes technologies, including continuous glucose monitoring (CGM) systems, support patients with diabetes in their daily struggle with achieving a good glucose control. However, shortly after the first CGM systems appeared on the market, also the first concerns about adverse skin reactions were raised. Most patients claimed to suffer from (sometimes severe) skin irritation, or even allergy, which they related to the (acrylate-based) adhesive part of the device. For a long time the actual substance that caused these skin reactions with, for example, the Flash Glucose Monitoring system (iscCGM; Freestyle® Libre) could not be identified; however, recently Belgian and Swedish dermatologists reported that the majority of their patients that have developed a contact-allergic while using iscCGM react sensitively to a specific acrylate, that is, isobornyl acrylate (IBOA). Subsequently they showed by means of gas chromatography-mass spectrometry that this substance is present in the case of the glucose sensor attached by an adhesive to the skin. We report three additional cases from Germany, including a 10-year-old boy, suffering from severe allergic contact dermatitis to IBOA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In some cases, this has been linked to the presence of isobornyl acrylate, a skin sensitizer that can cause an additional spreading allergic reaction (119-121).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [119]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Herman, A., Aerts, O., Baeck, M., Bruze, M., De Block, C., Goossens, A., Hamnerius, N., Huygens, S., Maiter, D., Tennstedt, D., et al. (2017) · Contact Dermatitis · doi:10.1111/cod.12866 · Cited by 192
Self-citationAdhesives Used for Diabetes Medical Devices: A Neglected Risk With Serious Consequences?
Heinemann, L., & Kamann, S. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816662949 · Cited by 74
Self-citationSchwensen, J. F. B., Friis, U. F., Zachariae, C. O. C., & Johansen, J. D. (2016) · Contact Dermatitis · doi:10.1111/cod.12503 · Cited by 62
Contact allergy to components of glue in insulin pump infusion sets
Busschots, A. M., Meuleman, V., Poesen, N., & Dooms‐Goossens, A. (1995) · Contact Dermatitis · doi:10.1111/j.1600-0536.1995.tb00554.x · Cited by 61
Two decades of occupational (meth)acrylate patch test results and focus on isobornyl acrylate
Christoffers, W. A., Coenraads, P., & Schuttelaar, M. L. A. (2013) · Contact Dermatitis · doi:10.1111/cod.12023 · Cited by 47
Isobornyl acrylate: an impurity in alkyl glucosides
Foti, C., Romita, P., Rigano, L., Zimerson, E., Sicilia, M., Ballini, A., Ghizzoni, O., Antelmi, A., Angelini, G. D., Bonamonte, D., et al. (2015) · Cutaneous and Ocular Toxicology · doi:10.3109/15569527.2015.1055495 · Cited by 47
Research works printed but not linked: 1
- Foti C, 2016, Cutan Ocul Toxicol, 35, 115
Cited by
7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s007 · Cited by 358
7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
7. Diabetes Technology: Standards of Care in Diabetes — 2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s007 · Cited by 301
7. Diabetes Technology: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s007 · Cited by 281
7. Diabetes Technology: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s007 · Cited by 250
Metadata
- Authors
- Kamann, S., Aerts, O., & Heinemann, L.
- Affiliations
- Pöcking, Germany
- University of Antwerp (BE)
- Science & Co, Düsseldorf, Deutschland, Germany
- Corresponding author
- Kamann, Stefanie
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2018-03-15
- Volume
- 12
- Issue
- 3
- Pages
- 630-633
- ISSN
- 1932-2968 (ISSN-L)
- PMC
- PMC6154227
- OpenAlex
- W2793234916
- Cited by
- 85
- References
- 6
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 7 · 2023: 4 · 2022: 11 · 2021: 13 · 2020: 19 · 2019: 17 · 2018: 6
- FWCI
- 14.88
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Diabetes Science and Technology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Health Sciences › Medicine › Dermatology › Skin Diseases and Diabetes
- Keywords
- allergic contact dermatitis, isobornyl acrylate, continuous glucose monitoring, skin irritation, diabetes technology, pediatric patients
- MeSH terms
- Acrylates, Adhesives, Camphanes, Child, Diabetes Mellitus, Type 1, Humans, Male, Blood Glucose Self-Monitoring, Dermatitis, Allergic Contact
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Further Evidence of Severe Allergic Contact Dermatitis From Isobornyl Acrylate While Using a Continuous Glucose Monitoring System. https://app.cochat.ai/papers/10.1177/1932296818762946
- The paper
- Kamann, S., Aerts, O., & Heinemann, L. (2018). Further Evidence of Severe Allergic Contact Dermatitis From Isobornyl Acrylate While Using a Continuous Glucose Monitoring System. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296818762946
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.